ACTRN12611000569909已完成4 期
Oral silodosin on lower urinary tract symptoms due to double-J stent
Chung Jing Wang0 个研究点目标入组 45 人开始时间: 2011年6月3日最近更新:
适应症
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 发起方
- 入组人数
- 45
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Treatment
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 20 Years 至 60 Years（—）
- 性别
- All
入选标准
- •patients, with insertion of a double-J ureteral stent after ureteroscopic stone removal, were enrolled into the study
排除标准
- •benign prostatic hyperplasia-related lower urinary symptoms(International Prostate Symptom Score greater greater than 7); a history of interstitial cystitis, chronic cystitis, chronic prostatitis, or stent insertion; and chronic medication with alpha-blockers or analgesics
研究者
相似试验
已完成
不适用
Efficacy and safety of silodosin on lower urinary tract symptoms (LUTS) in patients with Parkinson's diseases diseaseParkinson's diseaseJPRN-UMIN000008138Juntendo University School of Medicine100
尚未招募
不适用
The clinical effect of Silodosin for lower urinary tract symptoms after permanent prostate brachytherapyProstate cancerJPRN-UMIN000004146Kobe University Hospital60
进行中（未招募）
1 期
A clinical study, which evaluates the effectiveness and the safety of a new medication for prostatic hyperplasia, silodosin, when administered under normal conditions of use in a wide European population.EUCTR2011-000045-20-ESRECORDATI S.p.A
进行中（未招募）
1 期
Effectiveness and safety of silodosin in the treatment of patients with benign prostatic hyperplasia.Benign prostatic hyperplasia.EUCTR2011-000045-20-RORECORDATI S.p.A
进行中（未招募）
不适用
Effectiveness and safety of silodosin in the treatment of LUTS in patients with benign prostatic hyperplasia: a European phase IV clinical study (the Silodosin in Real-life Evaluation study) - SIREBenign prostatic hyperplasia.MedDRA version: 13.1Level: PTClassification code 10004446Term: Benign prostatic hyperplasiaSystem Organ Class: 10038604 - Reproductive system and breast disordersEUCTR2011-000045-20-HURECORDATI S.p.A1,000